4 小时
News-Medical.Net on MSN4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNAPLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well ...
中国农大新闻网讯 近日,中国农业大学土地科学与技术学院廖人宽教授团队在合成DNA纳米材料的环境应用研究方面取得新进展。相关成果在美国化学会(ACS)旗下纳米科学与技术专业期刊 ACS Nano(Nature ...
Coralville-based Integrated DNA Technologies, a global leader in genomics solutions, has joined forces with Elegen, a leader in next-generation DNA ...
1 天
AZoLifeSciences on MSNWhat’s Next in Synthetic Biology?The field of synthetic biology is revolutionizing biomedicine, with applications in CAR-T cell therapy and biosensor-based ...
4basebio PLC has been granted Good Manufacturing Practice (GMP) certification by the UK’s Medicines and Healthcare products ...
为解决胚胎实验伦理问题,研究人员探索合成 DNA(synDNA)技术,或可创造非存活胚胎,意义重大。 未来,合成 DNA(synDNA)技术或许能创造用于研究的非存活胚胎,有望避开胚胎实验的伦理争议。本文探讨了该技术的运作方式、可能缓解的伦理问题以及现存挑战。
6 天
Zacks.com on MSNPromising Genomics & Synthetic Biology Stocks to Consider in 2025Investors interested in the Genomics and Synthetic Biology theme should consider these stocks: Twist Bioscience Corporation, ...
PLC ("4basebio" or the "Company") 4basebio Receives GMP Licence for its UK DNA Manufacturing Facility. Cambridge, UK, 2 April 2025 – 4basebio PLC (AIM: 4BB), an innovat ...
IDT and Elegen partner to launch an early access program offering long, clonal gene synthesis and high-complexity genes up to 15 kb.
Biology — the science of life, living things and the processes that keep us all running — links up in essential ways with ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果